<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>cryo-electron microscopy in structural biology &#8211; Science</title>
	<atom:link href="https://scienmag.com/tag/cryo-electron-microscopy-in-structural-biology/feed/" rel="self" type="application/rss+xml" />
	<link>https://scienmag.com</link>
	<description></description>
	<lastBuildDate>Mon, 13 Jul 2026 21:30:14 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1</generator>

<image>
	<url>https://scienmag.com/wp-content/uploads/2024/07/cropped-scienmag_ico-32x32.jpg</url>
	<title>cryo-electron microscopy in structural biology &#8211; Science</title>
	<link>https://scienmag.com</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">73899611</site>	<item>
		<title>Unusual Epigenetic Modifier Drives Some Cancers While Inhibiting Others</title>
		<link>https://scienmag.com/unusual-epigenetic-modifier-drives-some-cancers-while-inhibiting-others/</link>
		
		<dc:creator><![CDATA[Juliet Wilcox]]></dc:creator>
		<pubDate>Mon, 13 Jul 2026 21:30:14 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[chromatin modification mechanisms]]></category>
		<category><![CDATA[cryo-electron microscopy in structural biology]]></category>
		<category><![CDATA[epigenetic regulation in cancer]]></category>
		<category><![CDATA[gene activation via histone methylation]]></category>
		<category><![CDATA[histone H3K4 methylation]]></category>
		<category><![CDATA[MLL4 histone methyltransferase]]></category>
		<category><![CDATA[novel insights into epigenetic enzyme architecture]]></category>
		<category><![CDATA[paradoxical cancer roles of epigenetic modifiers]]></category>
		<category><![CDATA[role of p53 in tumor suppression]]></category>
		<category><![CDATA[structure of MLL4 complex]]></category>
		<category><![CDATA[tissue differentiation and cancer]]></category>
		<category><![CDATA[transcriptional regulation in cancer]]></category>
		<guid isPermaLink="false">https://scienmag.com/unusual-epigenetic-modifier-drives-some-cancers-while-inhibiting-others/</guid>

					<description><![CDATA[In a remarkable breakthrough, researchers at Rockefeller University have unveiled novel insights into the epigenetic modifier MLL4, a protein complex with paradoxical roles in cancer biology. While MLL4 propels disease progression in certain leukemias, it paradoxically suppresses solid tumors, functioning in concert with the crucial tumor-suppressor protein p53. This discovery sheds new light on the [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>In a remarkable breakthrough, researchers at Rockefeller University have unveiled novel insights into the epigenetic modifier MLL4, a protein complex with paradoxical roles in cancer biology. While MLL4 propels disease progression in certain leukemias, it paradoxically suppresses solid tumors, functioning in concert with the crucial tumor-suppressor protein p53. This discovery sheds new light on the multifaceted mechanisms governing gene regulation and cancer.</p>
<p>MLL4 belongs to the mixed-lineage leukemia (MLL) family of histone lysine methyltransferases, enzymes that particularly methylate histone H3 at lysine 4 (H3K4), a modification pivotal for activating gene transcription. Notably, MLL4 is the largest nuclear protein in mammalian cells and serves as a transcriptional cofactor essential for tissue differentiation, development, and context-dependent regulation of cancer-related genes.</p>
<p>The pioneering work led by Robert Roeder’s Laboratory of Biochemistry and Molecular Biology employed an innovative combination of cryo-electron microscopy (cryo-EM), genetics, and a sophisticated in vitro transcription system developed in their lab to resolve the full nine-subunit architecture of MLL4, including five unique components. The high-resolution structural data revealed that MLL4 anchors rigidly to nucleosomes but extends a flexible arm to recognize histone targets for methylation, effectively switching genes on.</p>
<p>Strikingly, the researchers discovered a unique intramolecular fold where MLL4&#8217;s N-terminal region folds back onto its C-terminal domain, forming a structural architecture essential not only for histone methylation but also for facilitating p53-dependent transcriptional activation. Genetic knockout experiments demonstrated that deleting MLL4 impairs transcription of p53 target genes, which are vital for genome protection mechanisms such as DNA repair, cell cycle arrest, and apoptosis.</p>
<p>This newfound co-activator role of MLL4 in assisting p53’s function signifies a second, distinct mechanism by which MLL4 influences gene regulation, beyond its canonical methyltransferase activity. The collaboration between MLL4 and p53 underscores a complex regulatory network that balances oncogenic and tumor-suppressive signals depending on cellular context.</p>
<p>The study’s implications are far-reaching, offering a molecular explanation for MLL4’s dualistic behavior in leukemia and solid tumors. Moving forward, the team aims to elucidate how MLL4 interacts with other leukemia-associated transcription factors, potentially unveiling therapeutic targets that exploit its context-dependent functions.</p>
<p>This research not only deepens our understanding of epigenetic regulation but also highlights MLL4 as a critical modulator in cancer biology, making it a compelling focus for future cancer therapies and transcriptomic studies.</p>
<hr />
<p><strong>Subject of Research</strong>: Epigenetic regulation and cancer transcription mechanisms<br />
<strong>Article Title</strong>: Molecular Mechanisms of the MLL4 Complex in H3K4 Methylation and p53-Dependent Transcription Activation<br />
<strong>Web References</strong>: <a href="https://www.cell.com/molecular-cell/fulltext/S1097-2765(26)00312-6">https://www.cell.com/molecular-cell/fulltext/S1097-2765(26)00312-6</a><br />
<strong>Image Credits</strong>: Lori Chertoff/The Rockefeller University<br />
<strong>Keywords</strong>: Leukemia, Epigenetics, Transcription, Cancer, MLL4, p53, Histone Methylation</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">172222</post-id>	</item>
		<item>
		<title>Physiologically Relevant Intermediate State of Potassium Channel</title>
		<link>https://scienmag.com/physiologically-relevant-intermediate-state-of-potassium-channel/</link>
		
		<dc:creator><![CDATA[Jason Bradley]]></dc:creator>
		<pubDate>Fri, 03 Oct 2025 11:41:10 +0000</pubDate>
				<category><![CDATA[Medicine]]></category>
		<category><![CDATA[cellular excitability mechanisms]]></category>
		<category><![CDATA[computational modeling in neuroscience]]></category>
		<category><![CDATA[cryo-electron microscopy in structural biology]]></category>
		<category><![CDATA[electrical signaling in excitable tissues]]></category>
		<category><![CDATA[electrophysiological responses in neurons]]></category>
		<category><![CDATA[gating mechanisms of ion channels]]></category>
		<category><![CDATA[molecular dynamics of voltage sensing]]></category>
		<category><![CDATA[pharmacological modulation of potassium channels]]></category>
		<category><![CDATA[physiologically relevant intermediate state]]></category>
		<category><![CDATA[tetrameric assembly of Kv channels]]></category>
		<category><![CDATA[transient conformations in ion channels]]></category>
		<category><![CDATA[voltage-gated potassium channels]]></category>
		<guid isPermaLink="false">https://scienmag.com/physiologically-relevant-intermediate-state-of-potassium-channel/</guid>

					<description><![CDATA[In a groundbreaking advance that stands to deepen our understanding of cellular excitability, researchers have unveiled a physiologically-relevant intermediate state structure of a voltage-gated potassium channel, illuminating the intricate mechanisms that govern electrical signaling in cells. Voltage-gated potassium channels (Kv channels) are critical components of excitable membranes, responsible for repolarizing cells after action potentials and [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>In a groundbreaking advance that stands to deepen our understanding of cellular excitability, researchers have unveiled a physiologically-relevant intermediate state structure of a voltage-gated potassium channel, illuminating the intricate mechanisms that govern electrical signaling in cells. Voltage-gated potassium channels (Kv channels) are critical components of excitable membranes, responsible for repolarizing cells after action potentials and thus shaping electrophysiological responses in neurons, muscle cells, and many other excitable tissues. Despite decades of research, the transient intermediate conformations these channels adopt during gating have remained enigmatic, limiting the ability to fully grasp their functional dynamics and pharmacological modulation.</p>
<p>The recent work, published in Nature Communications by Kyriakis and colleagues, employs a cutting-edge combination of cryo-electron microscopy, electrophysiology, and computational modeling to capture and characterize an elusive intermediate conformation of the Kv channel. Unlike previous structures that represent either the fully open or closed states, this intermediate state reflects a physiologically relevant snapshot of the channel in transition. This discovery profoundly expands the molecular understanding of voltage sensing and gating mechanisms, offering a crucial missing piece in the puzzle of how electrical signals propagate and are finely controlled at the molecular level.</p>
<p>The voltage-gated potassium channel is composed of a tetrameric assembly forming a central pore that selectively conducts K+ ions, underpinning the ionic basis of membrane potential. Each subunit contains six transmembrane helices, with the S1–S4 segments forming the voltage-sensor domain (VSD) and the S5–S6 segments constituting the pore domain. Upon membrane depolarization, conformational changes in the VSD are transduced to the pore, prompting it to open and allow potassium efflux. The intricate choreography of these structural transitions has been challenging to capture experimentally due to their transient nature and rapid kinetics.</p>
<p>Kyriakis et al. overcame these barriers by stabilizing the channel in an intermediate gating state through strategic mutagenesis and voltage-clamp fluorometry, followed by high-resolution cryo-EM imaging. Their approach allowed visualization of the VSD in a partially activated conformation, uncoupled from the pore’s fully open or closed status. Structural analysis revealed that segments S4 exhibited partial outward movement relative to the membrane plane, while the pore domain adopted a conformation suggestive of a non-conducting but poised configuration.</p>
<p>This intermediate state sheds light on the finely tuned electromechanical coupling between the voltage sensor and the pore, suggesting a two-step gating mechanism rather than a simple binary transition. Such stepwise gating is likely essential for the channel’s high fidelity and kinetic precision, preventing errant ion flow and providing opportunities for modulation by cellular factors or drugs. The data also revealed key interactions between gating charges on S4 and negatively charged residues in the surrounding helices, stabilizing this intermediate conformation and underscoring the electrostatic intricacies driving the gating process.</p>
<p>Importantly, the discovery provides new insight into the potential pharmacological targeting of Kv channels. Many neurological disorders, cardiac arrhythmias, and other pathologies arise from channel dysfunction or aberrant gating behaviors. Understanding the structural basis of intermediate gating states opens avenues for the design of novel modulators that stabilize specific conformations, thus offering therapeutic precision that was previously unattainable. This structural framework suggests that allosteric sites accessible only during intermediate conformations might be exploited to develop drugs with reduced side effects by avoiding interference with fully open or closed states.</p>
<p>Beyond pharmacology, this finding enhances our fundamental comprehension of voltage sensing transduction, a highly conserved mechanism across diverse ion channel families. The ability to visualize the intermediate state bridges a critical knowledge gap between static structural snapshots and dynamic gating processes inferred from electrophysiology. This integrative view promises to refine computational models of membrane excitability, permitting simulations that more faithfully represent the kinetic and energetic landscape traversed during channel operation.</p>
<p>The study also carries implications for understanding how mutations associated with channelopathies affect gating. Certain disease-linked variants might preferentially destabilize intermediate states, skewing the balance of open and closed channel populations and thus altering cellular excitability. Structural insights into the intermediate conformations provide a template for interpreting how subtle sequence alterations translate into profound physiological consequences, offering a roadmap for precision medicine strategies targeting mutant channels.</p>
<p>Technically, the successful resolution of this intermediate state underscores the power of modern cryo-EM methodologies combined with voltage clamp approaches. By carefully controlling the ionic and voltage environment and employing mutants to trap conformations, the team navigated past the technical challenges that have historically limited visualization of fleeting channel states. This approach sets a new standard for structural biology studies of dynamic membrane proteins, suggesting that other elusive intermediate states in ion channels and transporters could soon be similarly unraveled.</p>
<p>Furthermore, the results provoke intriguing questions about the evolutionary optimization of voltage-gated channel gating. The observed stepwise conformational changes may reflect a finely honed balance between speed, order, and energy efficiency, crucial for the rapid signaling requirements of complex organisms. Future comparative studies of related channels from different species could elucidate how structural intermediates have adapted to distinct physiological demands.</p>
<p>Another compelling aspect is the potential for investigating allosteric modulation by auxiliary subunits or lipids that interact with Kv channels in native membranes. The intermediate state structure provides a scaffold to probe how these interacting partners influence gating transitions, adding layers of regulatory complexity that extend beyond the canonical pore and voltage sensor domains. This holistic view will be vital for understanding channel behavior in situ, where multiple factors converge to fine-tune electrical signaling.</p>
<p>As electrophysiology and structural biology increasingly converge, this work exemplifies the promise of an integrated approach to unravel dynamic molecular processes central to life. Capturing an intermediate gating state not only enriches the ion channel field but serves as a paradigm for studying conformational landscapes of other dynamic proteins critical to health and disease.</p>
<p>In conclusion, the elucidation of a physiologically relevant intermediate state structure of a voltage-gated potassium channel marks a seminal advance, providing unprecedented molecular insight into the gating mechanics that underpin electrical signaling. By bridging the gap between static structures and electrophysiological function, this study opens fresh avenues for hypothesis-driven drug design, disease mechanism exploration, and evolutionary biology. It redefines our understanding of one of the most fundamental biological nanomachines and sets a new trajectory for future research into the dynamic world of excitable membranes.</p>
<p>Subject of Research: Voltage-gated potassium channel gating mechanism and structure</p>
<p>Article Title: A physiologically-relevant intermediate state structure of a voltage-gated potassium channel</p>
<p>Article References:<br />
Kyriakis, E., Sastre, D., Eldstrom, J. et al. A physiologically-relevant intermediate state structure of a voltage-gated potassium channel. Nat Commun 16, 8814 (2025). https://doi.org/10.1038/s41467-025-64060-3</p>
<p>Image Credits: AI Generated</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">85692</post-id>	</item>
	</channel>
</rss>
